Skip to main content

Minerva Neurosciences, Inc.

NERV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001598646

No open-market purchases or sales by Minerva Neurosciences, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $234.8M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Minerva Neurosciences, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of NERV: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders6846−22
Shares27.2M24.7M−2.55M (−9.4%)
Value$63.2M$42.9M−$20.2M (−32.0%)

New holders (3)

Institutions that held Minerva Neurosciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to NERV in Q3 2021
InstitutionSharesValue% of portfolio
Rafferty Asset Management, LLC48,865$85.0K0.00%
Group One Trading, L.P.42,006$73.0K0.00%
Two Sigma Securities, LLC16,788$29.0K0.01%

Sold out (25)

Institutions that held Minerva Neurosciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.